Insight Molecular Diagnostics (IMDX)'s 30-day implied volatility (IV30) was 120.7% at the close on October 14, 2026, up from 75.6% the day before, against a 52-week range of 66.3% to 153.0%. Its 20-day historical volatility was 123.1%.
Data as of October 14, 2026.